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It is over. The outbreak of the enterohaemorrhagic 
Escherichia coli (EHEC) O104:H4 infection that had 
its major focus in Germany [1] and affected people in 
many other European countries has officially come 
to an end [2]. While the media coverage has been 
decreasing, the scientific community has been work-
ing to understand the reason why this dramatic out-
break occurred. We have learnt that the pathogen 
is not a totally new clone, but is a slight variant of 
a known – although rarely described – EHEC, called 
HUSEC-41 [3] with an extended-spectrum beta-lacta-
mase (ESBL) resistance. Furthermore, the strain car-
ries genes typically found in two types of pathogenic 
E. coli, the enteroaggregative E. coli (EAEC) and EHEC 
[4,5]. It specifically carries the genes for the classi-
cal haemolytic uraemic syndrome (HUS)-associated 
Shiga toxin 2.
Despite the efforts that have been made, major ques-
tions currently remain unanswered, such as why 
women were affected more than men, why the attack 
rate was so high, what the primary source was and 
what the reservoir is, how long people are carriers, 
what the importance of the ESBL resistance is, what 
the infectious dose is for this outbreak strain and what 
the role of secondary transmission is via symptomatic 
or asymptomatic carriers, directly to other persons or 
indirectly via an index source, such as food.
It is known that up to 15% of EHEC cases can be a result 
of secondary transmission arising from household 
contact with people who have sporadic EHEC infec-
tions [6]. In this issue of Eurosurveillance, two articles, 
Aldabe et al. [7] and Hauri et al. [8] report on secondary 
transmission during the EHEC O104:H4 outbreak. The 
first reports on a symptomatic man who transmitted 
EHEC to his wife and young daughter during the EHEC 
O104:H4 infection in France [7]. Interestingly, the EHEC 
that was isolated from the mother apparently lost its 
ESBL resistance, confirming the known mobility of 
plasmids carrying resistance genes. This fact should 
be taken into consideration in diagnostic laboratories 
if ESBL resistance of EHEC O104:H4 is used for primary 
selection of the pathogen from stools without using 
also non-selective enrichment and detection of Shiga 
toxin genes.
The second article [8] illustrates in detail the history 
of six possible household transmissions, two possible 
nosocomial and one possible laboratory transmission 
in the German State of Hesse, where satellite clus-
ters occurred. These cases throw light on three crucial 
issues. First, secondary transmission of EHEC O104:H4 
was shown not to be more frequent than expected. 
Second, the importance of microbiological serotyp-
ing was highlighted, as EHEC of other HUS-associated 
serogoups (O157, O91, and O103) were also identified 
during the outbreak. Serotyping data are rarely avail-
able, due to the need for time-consuming techniques 
usually only carried out in specialised reference labs. 
This shows the need for the development of rapid sero- 
and pathotyping methods for all HUS-associated E. coli 
strains. Third, infection control in hospitalised patients 
with EHEC infection needs specific consideration, as 
does laboratory safety in the handling of EHEC. It is not 
without reason that in most countries of the European 
Union EHEC is classified as a biosafety level (BSL)-3** 
microorganism (but no high-efficiency particulate air 
(HEPA) filter is required).
Both articles illustrate the importance of personal 
hygiene in preventing secondary transmission. In gen-
eral, EHEC does not behave differently to any other 
organism transmitted via the faecal–oral route, but 
our ‘preventive doors’ for such organisms seem to stay 
wide open. We have become used to the fact that hun-
dreds of thousands of Europeans have diarrhoea every 
year and a certain lack of basic hygiene seems to be 
acceptable, as usually nothing very severe happens. We 
often lack time for hand hygiene as we consider it not 
to be of great importance. However, diarrhoea is not a 
normal state. We forget that most enteropathogens are 
less infectious than EHEC or do not lead to such severe 
disease with such social visibility. This brings us to the 
biggest challenge. Circulating highly pathogenic and/
or multiresistant microorganisms can be detected at 
a very early stage, before large outbreaks of disease 
occur. Preventive microbiology is a basis for preventive 
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medical advice and decision-making to protect people 
from infections. In future, European-wide coordina-
tion of preventive microbiology will be crucial for early 
detection of major health threats caused by infec-
tious diseases. Its success will depend on our interna-
tional and interdisciplinary efforts to foster protection 
against infection.
This outbreak is over. Let us get prepared!
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